ANE Breast Health Formula
Natural health product licensed in Canada
- Other names
- ANE Breast Support, ANE Breast Therapy
- Licence holder
- ANE Biotech Inc.
- NPN or DIN-HM
- 80123060
- Status
- Active licence
- Licence date
- 7 February 2023
- Revision date
- 18 October 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 100 mg | Not calculated |
| Vitex agnus-castus Source : Vitex agnus-castus - Fruit | 50 mg | Not calculated |
| Brassica oleracea var. botrytis Source : Brassica oleracea var. botrytis - Sommité (herbe) | 10 mg | Not calculated |
| Carica papaya Source : Carica papaya - fruit | 50 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropyl méthylcellulose, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine (as a hormone normaliser) to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of/Provides antioxidants that help fight/protect (cells) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of/Provides antioxidants. Source of (an) antioxidant(s)/Provides (an) antioxidant(s).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80123060
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging